22Aug
16Mar
Skyline Medical Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Business Update
Skyline Medical Inc., developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and 12 months ended December 31, 2016 and provides a business update. Read more >>
02Mar
Skyline Medical Awarded Innovative Technology Contract from Vizient, Inc. for STREAMWAY® System
Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”),producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal has received an Innovative Technology contract from Vizient, Inc. Read more >>
14Jan
Skyline Medical Announces Pricing of Public Offering of Common Stock and Warrants
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced the pricing of a firm commitment underwritten public offering. Read more >>
03Dec
Skyline Medical Names Carl Schwartz Chief Executive Officer, Appoints Richard Gabriel to Board of Directors
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced changes in executive management and the board of directors. Read more >>
25Nov
Skyline Receives Canada Approval For STREAMWAY System
Going back to the biotech angle, Skyline Medical Inc. (NASDAQ: SKLN) announced that it received approval for its STREAMWAY System and related disposables from Canadian authorities. The company said that a number of distributors had expressed interest in selling STREAMWAY into Canada’s health-care system. Read more >>
23Nov
Skyline Medical (SKLN) Reports Approval in Canada to Market STREAMWAY System
Skyline Medical Inc. (NASDAQ: SKLN) announces that it has received a Medical Device Establishment License to sell the STREAMWAY System and related disposables in Canada. Read more >>
16Nov
Skyline Medical (Formerly Known as BioDrain Medical, Inc.) Reports Third Quarter 2016 Financial Results
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and nine months ended September 30, 2016. Read more >>
03Nov
Skyline Medical Expands Relationship with GLG Pharma to Include Exclusive Distribution of STREAMWAY in Poland and Other Central European Countries
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that it has agreed to grant GLG Pharma, LLC (“GLG”) exclusive rights to market and distribute the STREAMWAY® System in Poland and certain other countries in Central Europe. Read more >>
22Sep